136 related articles for article (PubMed ID: 34814390)
21. Long-term follow-up of patients with hyperthyroidism due to Graves' disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: a retrospective study.
Mazza E; Carlini M; Flecchia D; Blatto A; Zuccarini O; Gamba S; Beninati S; Messina M
J Endocrinol Invest; 2008 Oct; 31(10):866-72. PubMed ID: 19092290
[TBL] [Abstract][Full Text] [Related]
22. Thyroid function and intellectual development of infants nursed by mothers taking methimazole.
Azizi F; Khoshniat M; Bahrainian M; Hedayati M
J Clin Endocrinol Metab; 2000 Sep; 85(9):3233-8. PubMed ID: 10999814
[TBL] [Abstract][Full Text] [Related]
23. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy.
Gianetti E; Russo L; Orlandi F; Chiovato L; Giusti M; Benvenga S; Moleti M; Vermiglio F; Macchia PE; Vitale M; Regalbuto C; Centanni M; Martino E; Vitti P; Tonacchera M
J Endocrinol Invest; 2015 Sep; 38(9):977-85. PubMed ID: 25840794
[TBL] [Abstract][Full Text] [Related]
24. Early changes of thyroid hormone concentrations after (131)I therapy in Graves' patients pretreated or not with methimazole.
Pirnat E; Zaletel K; Gaberscek S; Fidler V; Hojker S
Nuklearmedizin; 2004 Aug; 43(4):129-34. PubMed ID: 15316580
[TBL] [Abstract][Full Text] [Related]
25. Treatment of hyperthyroidism with radioiodine: adjunctive therapy with antithyroid drugs reconsidered.
Velkeniers B; Cytryn R; Vanhaelst L; Jonckheer MH
Lancet; 1988 May; 1(8595):1127-9. PubMed ID: 2452940
[TBL] [Abstract][Full Text] [Related]
26. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
Alexander EK; Larsen PR
J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
[TBL] [Abstract][Full Text] [Related]
27. A patient-specific treatment model for Graves' hyperthyroidism.
Pandiyan B; Merrill SJ; Di Bari F; Antonelli A; Benvenga S
Theor Biol Med Model; 2018 Jan; 15(1):1. PubMed ID: 29310665
[TBL] [Abstract][Full Text] [Related]
28. Effect of antithyroid drugs on the occurrence of antibodies against type 2 deiodinase (DIO2), which are involved in hyperthyroid Graves' disease influencing the therapeutic efficacy.
Molnár I; Szentmiklósi JA; Gesztelyi R; Somogyiné-Vári É
Clin Exp Med; 2019 May; 19(2):245-254. PubMed ID: 30610492
[TBL] [Abstract][Full Text] [Related]
29. Management of Graves Thyroidal and Extrathyroidal Disease: An Update.
Kahaly GJ
J Clin Endocrinol Metab; 2020 Dec; 105(12):3704-20. PubMed ID: 32929476
[TBL] [Abstract][Full Text] [Related]
30. [The effect of propylthiouracil on the efficacy of radioiodine (I-131) therapy in graves hyperthyroidism].
de Souza MV; Buescu A; Vaisman M; de Souza HF; Luiz RR
Arq Bras Endocrinol Metabol; 2006 Dec; 50(6):1088-95. PubMed ID: 17221116
[TBL] [Abstract][Full Text] [Related]
31. [Methimazole versus methimazole and diphosphonates in hyperthyroid and osteoporotic patients].
Lupoli GA; Fittipaldi MR; Fonderico F; Panico A; Colarusso S; Di Micco L; Cavallo A; Costa L; Paglione A; Lupoli G
Minerva Endocrinol; 2005 Jun; 30(2):89-94. PubMed ID: 15988404
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and Safety of Long-Term Methimazole versus Radioactive Iodine in the Treatment of Toxic Multinodular Goiter.
Azizi F; Saadat N; Takyar MA; Abdi H; Mehran L; Amouzegar A
Endocrinol Metab (Seoul); 2022 Dec; 37(6):861-869. PubMed ID: 36415961
[TBL] [Abstract][Full Text] [Related]
33. Effect of Goiter Dispersion Formula on Serum Cytokines in Hyperthyroidism Patients with Neurologic Manifestations of Graves' Disease: A Randomized Trial on 80 Cases.
Tian WH; Wang Y; Yang R; Hu HB
J Altern Complement Med; 2018 May; 24(5):481-485. PubMed ID: 29406821
[TBL] [Abstract][Full Text] [Related]
34. Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication.
Ghadban WK; Zirie MA; Al-Khateeb DA; Jayyousi AA; Mobayedh HM; El-Aloosy AS
Saudi Med J; 2003 Apr; 24(4):347-51. PubMed ID: 12754531
[TBL] [Abstract][Full Text] [Related]
35. Bone turnover and cortical bone mineral density in the distal radius in patients with hyperthyroidism being treated with antithyroid drugs for various periods of time.
Olkawa M; Kushida K; Takahashi M; Ohishi T; Hoshino H; Suzuki M; Ogihara H; Ishigaki J; Inoue T
Clin Endocrinol (Oxf); 1999 Feb; 50(2):171-6. PubMed ID: 10396358
[TBL] [Abstract][Full Text] [Related]
36. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
Akmal A; Kung J
Expert Opin Drug Saf; 2014 Oct; 13(10):1397-406. PubMed ID: 25156887
[TBL] [Abstract][Full Text] [Related]
37. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
[TBL] [Abstract][Full Text] [Related]
38. Long-term continuous methimazole or radioiodine treatment for hyperthyroidism.
Azizi F; Yousefi V; Bahrainian A; Sheikholeslami F; Tohidi M; Mehrabi Y
Arch Iran Med; 2012 Aug; 15(8):477-84. PubMed ID: 22827783
[TBL] [Abstract][Full Text] [Related]
39. Treatment of Subclinical Hyperthyroidism in the Elderly: Comparison of Radioiodine and Long-Term Methimazole Treatment.
Azizi F; Abdi H; Cheraghi L; Amouzegar A
Thyroid; 2021 Apr; 31(4):545-551. PubMed ID: 32811342
[No Abstract] [Full Text] [Related]
40. Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake.
Ruchała M; Sowiński J; Dolata M; Junik R; Gembicki M; Skiba A
Nucl Med Rev Cent East Eur; 2005; 8(1):28-32. PubMed ID: 15977144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
